ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADMA ADMA Biologics Inc

交易中 02-10 10:40:08 EST

16.56

+0.19

+1.16%

最高16.65	最低16.30	成交量12.72万
今开16.48	昨收16.37	日振幅2.14%
总市值39.41亿	流通市值38.73亿	总股本2.38亿
成交额209.68万	换手率0.05%	流通股本2.34亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADMA","market":"US","secType":"STK","nameCN":"ADMA Biologics Inc","latestPrice":16.56,"timestamp":1770738006300,"preClose":16.37,"halted":0,"volume":127187,"delay":0,"changeRate":0.011606597434330955,"floatShares":233862209,"shares":237997765,"eps":0.855978,"marketStatus":"交易中","change":0.19,"latestTime":"02-10 10:40:08 EST","open":16.48,"high":16.65,"low":16.3,"amount":2096817.7278870002,"amplitude":0.021381,"askPrice":16.56,"askSize":101,"bidPrice":16.55,"bidSize":38,"shortable":3,"etf":0,"ttmEps":0.855978,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":16.37,"preHourTrading":{"tag":"盘前","latestPrice":16.48,"preClose":16.37,"latestTime":"09:29 EST","volume":6108,"amount":100460.878008,"timestamp":1770733770012,"change":0.11,"changeRate":0.00672,"amplitude":0.02306},"postHourTrading":{"tag":"盘后","latestPrice":16.41,"preClose":16.37,"latestTime":"19:14 EST","volume":40487,"amount":662879.58,"timestamp":1770682458226,"change":0.04,"changeRate":0.002443,"amplitude":0.013439},"volumeRatio":0.430193,"impliedVol":0.6549,"impliedVolPercentile":0.6733},"requestUrl":"/m/hq/s/ADMA/tweets","defaultTab":"tweets","newsList":[{"id":"1120964558","title":"异动解读 | ADMA Biologics股价盘中大跌17.72%，财报符合预期难挡投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1120964558","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120964558?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:06","pubTimestamp":1754575593,"startTime":"0","endTime":"0","summary":"生物制药公司ADMA Biologics Inc今日盘中股价大幅下挫，跌幅高达17.72%，引发市场广泛关注。这一大幅下跌发生在公司发布第二季度财报后，尽管财报整体符合市场预期，但仍未能阻止股价的暴跌。根据公司最新发布的财报，ADMA Biologics第二季度调整后每股收益为14美分，与分析师预期一致，同时高于去年同期的13美分。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADMA"],"gpt_icon":0},{"id":"2557569306","title":"Adma Biologics Inc股价重挫17.85% 市值跌6.49亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557569306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557569306?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:35","pubTimestamp":1754573713,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时35分，Adma Biologics Inc股票出现波动，股价大幅下挫17.85%。截至发稿，该股报15.23美元/股，成交量122.696万股，换手率0.51%，振幅6.61%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.05%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213513a6d8fb14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213513a6d8fb14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"1114614347","title":"异动解读 | ADMA Biologics季度业绩符合预期，却意外盘前大跌9.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114614347","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114614347?lang=zh_cn&edition=full","pubTime":"2025-08-07 16:22","pubTimestamp":1754554963,"startTime":"0","endTime":"0","summary":"生物制药公司ADMA Biologics Inc今日盘前股价大跌9.82%，尽管公司最新公布的季度业绩基本符合市场预期。这一意外走势引发了投资者的广泛关注。值得注意的是，ADMA Biologics的股价在本季度曾上涨4.1%，今年迄今为止更是上涨了10.6%。尽管公司业绩总体表现不俗，但盘前大跌可能反映了投资者对未来增长前景的担忧。这种反应可能也与近期股价涨幅较大有关，部分投资者可能选择获利了结，进一步加剧了股价的下跌。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADMA"],"gpt_icon":0},{"id":"1133957442","title":"异动解读 | ADMA生物制品公司季报符合预期，股价却意外大跌10.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133957442","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133957442?lang=zh_cn&edition=full","pubTime":"2025-08-07 08:45","pubTimestamp":1754527511,"startTime":"0","endTime":"0","summary":"生物制药公司ADMA Biologics Inc在发布最新季度财报后，股价在周三夜盘交易中意外大跌10.73%，引发市场关注。尽管公司业绩基本符合预期，但投资者似乎对某些方面仍持谨慎态度。根据公司公布的财报，截至6月30日的季度调整后每股收益为14美分，与分析师预期一致，高于去年同期的13美分。这种反应可能也与近期股价涨幅较大有关，部分投资者可能选择获利了结。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADMA"],"gpt_icon":0},{"id":"2518244776","title":"Adma Biologics Inc2024财年实现净利润1.98亿美元，同比增加801.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518244776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518244776?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449682,"startTime":"0","endTime":"0","summary":"3月9日，Adma Biologics Inc公布财报，公告显示公司2024财年净利润为1.98亿美元，同比增加801.13%；其中营业收入为4.26亿美元，同比增加65.12%，每股基本收益为0.85美元。从资产负债表来看，Adma Biologics Inc总负债1.38亿美元，其中短期债务1.22百万美元，资产负债比为3.55，流动比率为0.06。机构评级：截至2025年3月9日，当前有3家机构对Adma Biologics Inc目标价做出预测，其中目标均价为27.33美元，其中最低目标价为25.00美元，最高目标价为32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000250abef98ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000250abef98ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA"],"gpt_icon":0},{"id":"2517910218","title":"Adma Biologics Inc盘中异动 急速拉升5.11%报17.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910218?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:42","pubTimestamp":1741185758,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时42分，Adma Biologics Inc股票出现波动，股价快速上涨5.11%。截至发稿，该股报17.88美元/股，成交量38.2961万股，换手率0.16%，振幅5.35%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.70%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224238a260cb48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224238a260cb48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2516670663","title":"坎托菲茨杰拉德公司：重申ADMA Biologics(ADMA.US)评级，由增持调整至增持评级, 目标价由25.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670663","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670663?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:54","pubTimestamp":1741100071,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申ADMA Biologics(ADMA.US)评级，由增持调整至增持评级, 目标价由25.00美元调整至25.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04225448522189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADMA"],"gpt_icon":0},{"id":"2516672229","title":"Adma Biologics Inc盘中异动 快速下跌8.47%报14.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516672229?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098761,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Adma Biologics Inc股票出现异动，股价急速下挫8.47%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.25%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223241a25f04e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223241a25f04e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"1116609081","title":"ADMA Biologics 2024年第四季度调整后每股收益（EPS）为0.14美元，低于预期的0.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116609081","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116609081?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:18","pubTimestamp":1741036692,"startTime":"0","endTime":"0","summary":"ADMA Biologics 2024年第四季度调整后每股收益（EPS）为0.14美元，低于预期的0.15美元。以上内容来自Benzinga Earnings专栏，原文如下：ADMA Biologics Q4 2024 Adj. EPS $0.14 Misses $0.15 Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA"],"gpt_icon":0},{"id":"1188235161","title":"ADMA Biologics 2024年第四季度 GAAP 每股收益 $0.46，销售额 $117.549M 超过预期 $112.800M","url":"https://stock-news.laohu8.com/highlight/detail?id=1188235161","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188235161?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:08","pubTimestamp":1741036126,"startTime":"0","endTime":"0","summary":"ADMA Biologics 2024年第四季度 GAAP 每股收益 $0.46，销售额 $117.549M 超过预期 $112.800M以上内容来自Benzinga Earnings专栏，原文如下：ADMA Biologics Q4 2024 GAAP EPS $0.46, Sales $117.549M Beat $112.800M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ADMA Biologics 2024年第四季度 GAAP 每股收益 $0.46，销售额 $117.549M 超过预期 $112.800M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA"],"gpt_icon":0},{"id":"2516535309","title":"Adma Biologics Inc盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516535309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516535309?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:26","pubTimestamp":1740774377,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时26分，Adma Biologics Inc股票出现异动，股价大幅上涨5.12%。截至发稿，该股报16.23美元/股，成交量157.227万股，换手率0.67%，振幅6.15%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.41%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301042618a2585202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301042618a2585202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"1181224715","title":"异动解读 | ADMA生物技术公司上涨5.21%,财务数据向好或为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1181224715","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181224715?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:10","pubTimestamp":1736953823,"startTime":"0","endTime":"0","summary":"ADMA Biologics Inc (ADMA) 今日盘中大涨5.21%,引起了市场的广泛关注。\n从公开的财务数据来看,这家生物技术公司最新季度实现营业收入1.2亿美元,净利润3591万美元,每股收益0.15美元,毛利5963万美元,财务数据向好或是推动股价上涨的主因。\n此外,机构评级给予较高评价也值得关注。公开资料显示,100%的分析机构对该股给予买入评级,未有持有或卖出评级,有力支撑了股价上行预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | ADMA生物技术公司上涨5.21%,财务数据向好或为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADMA"],"gpt_icon":0},{"id":"2503695628","title":"Adma Biologics Inc盘中异动 早盘急速上涨5.39%报17.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503695628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503695628?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951467,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Adma Biologics Inc股票出现波动，股价快速上涨5.39%。截至发稿，该股报17.20美元/股，成交量5.1367万股，换手率0.02%，振幅1.89%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.68%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223108a222fd7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223108a222fd7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2503835315","title":"Adma Biologics Inc盘中异动 早盘快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503835315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503835315?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:34","pubTimestamp":1736778892,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时34分，Adma Biologics Inc股票出现异动，股价快速下跌5.06%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.99%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223452a220405a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223452a220405a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2501278610","title":"Adma Biologics Inc盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501278610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501278610?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:32","pubTimestamp":1736263923,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时32分，Adma Biologics Inc股票出现异动，股价急速下挫5.10%。截至发稿，该股报18.16美元/股，成交量45.0653万股，换手率0.19%，振幅5.72%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为1.29%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107233203a218f592&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107233203a218f592&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2500972693","title":"Adma Biologics Inc盘中异动 股价大涨5.07%报18.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500972693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500972693?lang=zh_cn&edition=full","pubTime":"2025-01-03 01:16","pubTimestamp":1735838184,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日01时16分，Adma Biologics Inc股票出现异动，股价快速上涨5.07%。截至发稿，该股报18.02美元/股，成交量65.3496万股，换手率0.28%，振幅5.19%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.70%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103011624ab9c1be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103011624ab9c1be1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2492382159","title":"Adma Biologics Inc盘中异动 临近收盘快速下挫5.07%报17.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492382159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492382159?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:36","pubTimestamp":1734554165,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时36分，Adma Biologics Inc股票出现波动，股价大幅下挫5.07%。截至发稿，该股报17.68美元/股，成交量158.583万股，换手率0.67%，振幅6.98%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为2.57%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043605ab829ea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043605ab829ea5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2491351973","title":"Adma Biologics Inc盘中异动 临近收盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491351973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491351973?lang=zh_cn&edition=full","pubTime":"2024-12-13 04:36","pubTimestamp":1734035770,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日04时36分，Adma Biologics Inc股票出现波动，股价快速跳水5.04%。截至发稿，该股报18.64美元/股，成交量132.094万股，换手率0.56%，振幅5.07%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为1.58%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213043611ab73485a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213043611ab73485a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2488774986","title":"Adma Biologics Inc盘中异动 早盘股价大跌5.12%报19.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488774986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488774986?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:48","pubTimestamp":1733150880,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时48分，Adma Biologics Inc股票出现异动，股价急速下跌5.12%。截至发稿，该股报19.08美元/股，成交量53.6204万股，换手率0.23%，振幅4.53%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.09%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224800971b2edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224800971b2edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2487568297","title":"Adma Biologics Inc盘中异动 早盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487568297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487568297?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:57","pubTimestamp":1732892229,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时57分，Adma Biologics Inc股票出现异动，股价快速下跌5.15%。截至发稿，该股报20.71美元/股，成交量49.2393万股，换手率0.21%，振幅4.67%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.54%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129225709971aa7f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129225709971aa7f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.admabiologics.com","stockEarnings":[{"period":"1week","weight":-0.0646},{"period":"1month","weight":-0.088},{"period":"3month","weight":0.0212},{"period":"6month","weight":-0.0483},{"period":"1year","weight":-0.0203},{"period":"ytd","weight":-0.1025}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ADMA Biologics, Inc.于2004年6月24日在新泽西州注册成立。该公司是一家端到端的商业生物制药公司，致力于制造、营销和开发专门的生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有特定传染病风险的人。该公司的目标患者群体包括患有潜在免疫缺陷疾病或可能因医疗原因而受到免疫抑制的免疫功能受损个体。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.021016},{"month":2,"riseRate":0.5,"avgChangeRate":-0.014856},{"month":3,"riseRate":0.636364,"avgChangeRate":0.108134},{"month":4,"riseRate":0.636364,"avgChangeRate":0.024806},{"month":5,"riseRate":0.636364,"avgChangeRate":0.053968},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.056361},{"month":7,"riseRate":0.727273,"avgChangeRate":0.105206},{"month":8,"riseRate":0.272727,"avgChangeRate":0.003287},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.032166},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.041559},{"month":11,"riseRate":0.636364,"avgChangeRate":0.093715},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.060542}],"exchange":"NASDAQ","name":"ADMA Biologics Inc","nameEN":"ADMA Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ADMA Biologics Inc(ADMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ADMA Biologics Inc,ADMA,ADMA Biologics Inc股票,ADMA Biologics Inc股票老虎,ADMA Biologics Inc股票老虎国际,ADMA Biologics Inc行情,ADMA Biologics Inc股票行情,ADMA Biologics Inc股价,ADMA Biologics Inc股市,ADMA Biologics Inc股票价格,ADMA Biologics Inc股票交易,ADMA Biologics Inc股票购买,ADMA Biologics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ADMA Biologics Inc(ADMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}